Provention Bio Inc Revenue Growth Rates (PRVB), Current and Historic Growth - CSIMarket
CSIMarket
 


Provention Bio Inc   (NASDAQ: PRVB)
 

PRVB's Revenue Growth by Quarter and Year

Provention Bio Inc 's Revenue results by quarter and year




PRVB Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
4th Quarter December 10.81
3rd Quarter September 0.76
2nd Quarter June 0.75
1st Quarter March 0.58
FY 12.90





PRVB Revenue fourth quarter 2022 Y/Y Growth Comment
Provention Bio Inc achieved in the fourth quarter 2022, above Company average Revenue surge of 1401.81% year on year, to $ 10.81 millions.

Looking into fourth quarter 2022 results within Major Pharmaceutical Preparations industry 12 other companies have achieved higher Revenue growth. While Provention Bio Inc ' s Revenue doubling of 1401.81% ranks overall at the positon no. 56 in the fourth quarter 2022.




PRVB Revenue ( Y/Y Growth %) 2022
2021 2020 2019
4th Quarter December 1401.81 % - - -
3rd Quarter September 11.76 % - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   821.64 % - - -

Financial Statements
Provention Bio Inc 's fourth quarter 2022 Revenue $ 10.81 millions PRVB's Income Statement
Provention Bio Inc 's fourth quarter 2021 Revenue $ 0.72 millions Quarterly PRVB's Income Statement


PRVB Revenue (Quarter on Quarter Growth %)

2022
2021 2020 2019
4th Quarter December 1322.76 % 5.88 % - -
3rd Quarter September 1.33 % - - -
2nd Quarter June 29.31 % - - -
1st Quarter March -19.44 % - - -
FY (Year on Year)   821.64 % - - -




Revenue fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #13
Healthcare Sector #20
Overall #56

Revenue Y/Y Growth Statistics
High Average Low
1408.09 % 709.8 % 11.5 %
(Dec 31 2022)   (Sep 30 2022)
Revenue fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #13
Healthcare Sector #20
Overall #56
Revenue Y/Y Growth Statistics
High Average Low
1408.09 % 709.8 % 11.5 %
(Dec 31 2022)   (Sep 30 2022)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Provention Bio Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
1330.29 % 269.38 % -19.11 %
(Dec 31 2022)  


PRVB's IV. Quarter Q/Q Revenue Comment
Provention Bio Inc achieved in the IV. Quarter 2022 above company average sequential Revenue doubling of 1322.76%, to $ 10.81 millions, from $0.76 millions in the third quarter.
PRVB is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Major Pharmaceutical Preparations industry 9 other companies have achieved higher Revenue quarter on quarter growth. While Provention Bio Inc 's Revenue growth quarter on quarter, overall rank is 34.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #10
Healthcare Sector #16
Overall #34
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #10
Healthcare Sector #16
Overall #34
Revenue Q/Q Growth Statistics
High Average Low
1330.29 % 269.38 % -19.11 %
(Dec 31 2022)  


PRVB's IV. Quarter Q/Q Revenue Comment
Provention Bio Inc achieved in the IV. Quarter 2022 above company average sequential Revenue doubling of 1322.76%, to $ 10.81 millions, from $0.76 millions in the third quarter.
PRVB is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Major Pharmaceutical Preparations industry 9 other companies have achieved higher Revenue quarter on quarter growth. While Provention Bio Inc 's Revenue growth quarter on quarter, overall rank is 34.


Provention Bio Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
Cumulative Revenue 12 Months Ending $ 12.90 $ 2.80 $ 2.72 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) 360.7 % 2.87 % - - -
Seq. Revenue Growth (TTM) Overall Ranking # 2744 # 1689 # 0 # 0 # 0


Cumulative Revenue growth Comment
Provention Bio Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 1401.81% year on year, to $ 13 millions if the fiscal year would have ended in Dec 31 2022.
Provention Bio Inc 's trailing twelve months Revenue growth was higher than company's average 0% and higher than % growth in Sep 30 2022. And, Provention Bio Inc realized the fastest Revenue growth, in Major Pharmaceutical Preparations industry.
But from twelve months ended Sep 30 2022 rise was beneth at 360.7 % from $2.8 millions achieved in the period from Sep 30 2022 to Dec 31 2021.
Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at 0%.
The momentum is even more impressive from twelve months ended Sep 30 2022 exhibited at 360.7 % increase from $2.8 millions in the period from Sep 30 2022 to Dec 31 2021.

Provention Bio Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 146
Sector # 365
S&P 500 # 2744
Cumulative Revenue growth Comment
Provention Bio Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 1401.81% year on year, to $ 13 millions if the fiscal year would have ended in Dec 31 2022.
Provention Bio Inc 's trailing twelve months Revenue growth was higher than company's average 0% and higher than % growth in Sep 30 2022. And, Provention Bio Inc realized the fastest Revenue growth, in Major Pharmaceutical Preparations industry.
But from twelve months ended Sep 30 2022 rise was beneth at 360.7 % from $2.8 millions achieved in the period from Sep 30 2022 to Dec 31 2021.
Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at 0%.
The momentum is even more impressive from twelve months ended Sep 30 2022 exhibited at 360.7 % increase from $2.8 millions in the period from Sep 30 2022 to Dec 31 2021.

Provention Bio Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 146
Sector # 365
S&P 500 # 2744




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PRVB's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue doubling for the quarter ending Dec 31 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2022
Zymeworks Inc 1,925.63%$ 1,925.632 millions
Fresh Tracks Therapeutics Inc 1,871.15%$ 1,871.154 millions
Molecular Partners Ag1,762.30%$ 1,762.295 millions
Chimerix Inc 1,669.57%$ 1,669.565 millions
Spero Therapeutics Inc 1,628.90%$ 1,628.899 millions
Lyell Immunopharma Inc 1,614.60%$ 1,614.600 millions
Streamex Corp 1,587.50%$ 1,587.500 millions
Novan Inc 1,500.15%$ 1,500.153 millions
Foxo Technologies Inc 1,448.15%$ 1,448.148 millions
Provention Bio Inc 1,408.09%$ 1,408.089 millions
Orchard Therapeutics Plc1,346.38%$ 1,346.377 millions
Avricore Health Inc 1,339.95%$ 1,339.950 millions
4d Molecular Therapeutics Inc 1,256.52%$ 1,256.522 millions
Exicure Inc 928.05%$ 928.045 millions
Petvivo Holdings Inc 900.14%$ 900.135 millions
Aligos Therapeutics Inc 863.76%$ 863.760 millions
Mirum Pharmaceuticals Inc 789.29%$ 789.293 millions
Impel Pharmaceuticals Inc 767.94%$ 767.938 millions
Volitionrx Limited740.70%$ 740.695 millions


About Provention Bio Inc Revenue Growth Rates (PRVB), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Provention Bio Inc (CIK 1695357).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001493152-23-009516
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Provention Bio Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.